# A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

> **NCT07046780** · — · NOT_YET_RECRUITING · sponsor: **PENG YUAN** · enrollment: 90 (estimated)

## Conditions studied

- Solid Tumor Cancer
- Metastatic Solid Tumors
- Locally Advanced

## Interventions

- **DRUG:** Observation arm

## Key facts

- **NCT ID:** NCT07046780
- **Lead sponsor:** PENG YUAN
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-30
- **Primary completion:** 2027-07-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07046780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07046780, "A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07046780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*